Eosinophilic esophagitis with refractory response in a pediatric patient: A case report
Background: The treatment of eosinophilic esophagitis (EoE) is based on diets or drugs, with either being the first choice. Proton pump inhibitor (PPI) or swallowed topical corticosteroids (STC) are classically used, and more recently the use of dupilumab has been described as a therapeutic option....
Saved in:
| Main Authors: | Isamar carolina De Agrela-Mendes, Margarita Tomás Perez |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Colegio Mexicano de Inmunología Clínica y Alergia, A.C.
2025-06-01
|
| Series: | Revista Alergia México |
| Subjects: | |
| Online Access: | https://revistaalergia.mx/ojs/index.php/ram/article/view/1444 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical Guidelines of the Russian Gastroenterological Association on the Diagnostics and Treatment of Eosinophilic Esophagitis
by: V. T. Ivashkin, et al.
Published: (2019-01-01) -
Atopic condition of the esophagus - eosinophilic esophagitis - literature review
by: Artur Pastuszka, et al.
Published: (2025-04-01) -
Disease Burden and Spectrum of Symptoms That Impact Quality of Life in Pediatric Patients With Eosinophilic Esophagitis
by: Mirna Chehade, et al.
Published: (2024-01-01) -
Dupilumab in children with eosinophilic esophagitis: a retrospective multicenter study
by: Mohammed Hasosah, et al.
Published: (2025-02-01) -
Effectiveness of dupilumab treatment against refractory eosinophilic chronic rhinosinusitis
by: Daiki Nakashima, MD, et al.
Published: (2025-05-01)